Publication | Open Access

Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours

Molecular PharmacologyMedicinal ChemistryMedicinePten-deficient TumoursPi3kβ/δ InhibitorsNatural SciencesPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyRadiation OncologyPharmaceutical ChemistryTumor BiologyDrug Discovery